RT Journal Article
SR Electronic
T1 Genome-Wide Association Studies of retinal vessel tortuosity identify 173 novel loci, capturing genes and pathways associated with disease and vascular tissue pathomechanics
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.06.25.20139725
DO 10.1101/2020.06.25.20139725
A1 Mattia Tomasoni
A1 Michael Johannes Beyeler
A1 Ninon Mounier
A1 Eleonora Porcu
A1 Sofia Ortin Vela
A1 Alexander Luke Button
A1 Tanguy Corre
A1 Hana Abouzeid
A1 Murielle Bochud
A1 Daniel Krefl
A1 Sven Bergmann
YR 2021
UL http://medrxiv.org/content/early/2021/03/24/2020.06.25.20139725.abstract
AB Fundus images of the eye allow for non-invasive inspection of the microvasculature system of the retina, which is informative of systemic cardiovascular health. We set up a fully automated image processing pipeline enabling the massively parallelised annotation of such images in terms of vessel type (i.e., artery or vein) and quantitative morphological properties, such as tortuosity (“bendiness”). We tested seven different tortuosity measures by applying this pipeline to 175,821 fundus images from 62,751 genotyped subjects of the UK Biobank and the SKIPOGH cohort. We present the largest Genome-Wide Association Study (GWAS) of vessel tortuosity conducted to date, capturing 175 loci (173 of which are novel). Vessel-type specific GWA Studies revealed 114 and 63 loci, respectively. SNP-based heritability was highest when using the Distance Factor (curve over chord length) as tortuosity measure (h2=0.25 (SE=0.025) when considering all vessels types, h2=0.23 (SE=0.020) for arteries and h2=0.15 (SE=0.021) for veins). We showed that a number of alleles associated with retinal vessel tortuosity point to a common genetic architecture of this trait with CVD and metabolic syndrome. Using PascalX, a new high-precision method to aggregate SNP-wise effects on genes and annotated gene-sets, we obtained new insights into key components and the molecular pathways modulating the structural properties of the retinal vasculature. Our results shed new light on the genetics of vascular pathomechanisms and systemic disease, and highlight how GWAS can be used to inform phenotype extraction from high-dimensional data, such as images.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the Swiss National Science Foundation (#FN 310030_152724/1). The SKIPOGH study was supported by the Swiss National Science Foundation (#FN 33CM30-124087).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Cohort name: SKIPOGH. -Full name of Ethics Committee / Institutional Review Board (IRB) for the cohort: Ethics Committee of the Universities of Bern, Geneva, and Lausanne, Switzerland. -Decision made by ethical oversight body: approved / waived: approved Cohort name and Ethics Committee: UK Biobank - Decision made by ethical oversight body: approved / waived: approved, project 43805. All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data are made available by the UK Biobank Consortium.